Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5613968 | Journal of Arrhythmia | 2017 | 6 Pages |
Abstract
Ranolazine may prove beneficial in POAF prevention following cardiac surgeries. Although the pooled treatment effect is quite impressive with a reduction of more than 50% of risk of developing POAF, small number of studies and variation in ranolazine dose regimen in each study make our results inconclusive, but worthy of further investigation. That is why this result has to be interpreted as only hypothesis generating, rather than conclusion drawing.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chintan MD, MPH, Ankit MD, Kinjal MD,